157 related articles for article (PubMed ID: 24934372)
1. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
2. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
[TBL] [Abstract][Full Text] [Related]
3. A deeper understanding of the association between CTLA4 +49A/G and acute rejection in renal transplantation: an updated meta-analysis.
Gao JW; Zhou ZH; Guo SC; Guo YF; Guo F
Ren Fail; 2015 Feb; 37(1):165-74. PubMed ID: 25299395
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
7. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
Zhao HY; Duan HX; Gu Y
Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
[TBL] [Abstract][Full Text] [Related]
9. [Association of cytotoxic T lymphocyte-associated antigen-4+49A/G polymorphism with childhood type 1 diabetes mellitus: a meta-analysis].
Luo SY; Tan LN; Wei HY; Zhang YD; Chen YX
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Sep; 14(9):683-8. PubMed ID: 22989439
[TBL] [Abstract][Full Text] [Related]
10. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis.
Chang WW; Zhang L; Yao YS; Su H
Mol Biol Rep; 2012 Sep; 39(9):9159-65. PubMed ID: 22718509
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
12. Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a meta-analysis.
Tang ST; Tang HQ; Zhang Q; Wang CJ; Wang YM; Peng WJ
Gene; 2012 Oct; 508(2):165-87. PubMed ID: 22964358
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the association between CTLA-4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer.
Lee YH; Song GG
Neoplasma; 2014; 61(4):481-90. PubMed ID: 24712845
[TBL] [Abstract][Full Text] [Related]
15. The association between Cytotoxic T lymphocyte associated antigen-4, Fas, tumour necrosis factor-α gene polymorphisms and autoimmune hepatitis: a meta-analysis.
Qin B; Li J; Liang Y; Yang Z; Zhong R
Dig Liver Dis; 2014 Jun; 46(6):541-8. PubMed ID: 24629822
[TBL] [Abstract][Full Text] [Related]
16. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis.
Chen Z; Fei M; Fu D; Zhang L; Ma Y; Wang Y; Zhang F; Xia Q; Wang X
Gene; 2013 Mar; 516(2):263-70. PubMed ID: 23261825
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.
Li X; Zhang C; Zhang J; Zhang Y; Wu Z; Yang L; Xiang Z; Qi Z; Zhang X; Xiao X
J Clin Immunol; 2012 Jun; 32(3):530-9. PubMed ID: 22354566
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947
[TBL] [Abstract][Full Text] [Related]
19. CRP 1059 G/C and 1846G/A polymorphisms and cancer risk: a meta-analysis of 26,634 subjects.
Zhang Y; Jiang L
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):607-12. PubMed ID: 24835491
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
